Clinical Trials Directory

Trials / Unknown

UnknownNCT05309720

Dermal Substitution in Pediatric Burns

Dermal Substitution in Paediatric Burns: A Prospective Case Series

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Radboud University Medical Center · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

The standard treatment of deep dermal to full thickness burns is surgical removal of the burn followed by skin transplantation. Dermal substitutes are increasingly used in the treatment of deep burns to replace lost dermis. Preservation of the collagen and elastin in the acellular human dermal substitute Glyaderm provides a more elastic scar. It is unknown what the effect of Glyaderm on scar quality is in a solely paediatric population. The objective of this case series is to investigate scar maturation and scar quality when applying Glyaderm in deep dermal to full thickness burns in a pediatric population aged ≤15 years old.

Conditions

Interventions

TypeNameDescription
PROCEDUREGlyadermAll included patients will undergo full thickness removal of the burned skin or adequate debridement of all necrotic tissue. Next, the dermal substitute Glyaderm followed by a split thickness skin graft will be transplanted on the wound.

Timeline

Start date
2022-09-01
Primary completion
2025-11-01
Completion
2025-11-01
First posted
2022-04-04
Last updated
2024-04-12

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05309720. Inclusion in this directory is not an endorsement.